Obstetrics & Gynecology Email Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 2002;100:1230-1238
© 2002 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sampselle, C. M.
Right arrow Articles by Bondarenko, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sampselle, C. M.
Right arrow Articles by Bondarenko, I.

ORIGINAL RESEARCH

Urinary Incontinence Predictors and Life Impact in Ethnically Diverse Perimenopausal Women

Carolyn M. Sampselle, PhD, RNC, Siobán D. Harlow, PhD, Joan Skurnick, PhD, Linda Brubaker, MD and Irina Bondarenko, MS

From the School of Nursing, and Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan; Department of Preventive Medicine and Community Health, University of Medicine and Dentistry of New Jersey–New Jersey Medical School, Newark, New Jersey; and Department of Obstetrics and Gynecology, Loyola University Medical Center, Maywood, Illinois.

Address reprint requests to: Carolyn M. Sampselle, PhD, RNC, University of Michigan, School of Nursing, 400 North Ingalls, Ann Arbor, MI 48109-0482; E-mail: csampsll{at}umich.edu.


    ABSTRACT
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
OBJECTIVE: To document prevalence of mild, moderate, and severe urinary incontinence among ethnically diverse perimenopausal women, identify risk factors, and assess the effect of severity on women’s daily lives using treatment seeking, bother, and nighttime voiding as indicators.

METHODS: Baseline data from the longitudinal cohort of the Study of Women’s Health Across the Nation, a prospective, multiethnic, multisite study of the natural history of menopausal transition was used (n = 3302). Interview and self-completed questionnaires assessed most variables of interest. Body mass index and diabetes mellitus were measured clinically. Incontinence severity was derived by multiplying frequency by volume leaked. Risk factors and effect on treatment seeking, bother, and nighttime voiding were assessed by the construction of multiple logistic regression models for each ethnic group and the total population.

RESULTS: Mean age was 46.4 years. Incontinence prevalence was 57%, with nearly 15% categorized as moderate and 10% as severe. Biologic factors constituted the most important risk for severity, specifically perimenopausal compared with premenepausal status (odds ratio [OR] 1.35), body mass index (OR 1.04), diabetes mellitus (OR 1.55), and current smoking (OR 1.38). Nonwhite groups had lower risk, but the relationship of ethnicity is complex. Severity was associated with likelihood of discussing with a health care provider, with bothersomeness, and with likelihood of nighttime voiding.

CONCLUSION: Large numbers of perimenopausal women experience urinary incontinence with 25% wearing protection or changing undergarments on several days per week. Mutable factors predicting severity included body mass index and current smoking.

Despite extensive epidemiologic investigation of urinary incontinence in women, understanding of the scope of the problem is hampered by the lack of standard categorization of symptom severity and the paucity of ethnically diverse data. Urinary incontinence affects at least one in three women,1,2 but this estimate is derived from primarily white samples. Most women who report the condition in surveys do not actually seek treatment, and the scope of severity and its impact on daily life is not well understood.3 Age, parity, and body mass index (BMI) are generally accepted risk factors for urinary incontinence. The evidence is mixed regarding the contribution of menopausal status, cigarette smoking, and diabetes mellitus.

Prevalence estimates are typically based on any incontinence, where even a few drops of urine loss constitute a positive designation. The absence of clearly defined categories of severity complicates interpretation of prevalence estimates and the prediction of risk. Some studies have used frequency of incontinence episodes as an index of severity,4,5 but the volume of urine lost is also a critical component. For example, leakage might occur less than weekly but in an amount that is evident on outer clothing. Such an event would likely have more of a life impact than would a greater frequency of concealable incidents. Sandvik et al6 have validated a severity index of female incontinence that combines frequency and volume. This method was used to calculate urinary incontinence severity in the study presented here.

The purposes of this investigation were to document the prevalence of mild, moderate, and severe urinary incontinence among ethnically diverse perimenopausal women, to identify significant risk factors, and to assess the impact on daily life by testing the relationship of severity to treatment seeking, level of bother, and nighttime voiding.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
This report is based on data from the baseline visit of the Study of Women’s Health Across the Nation (SWAN), a prospective, multiethnic, multisite study of the natural history of the menopausal transition. The SWAN study sites are in seven locations: Boston, Chicago, the Detroit area, Los Angeles, Newark, Pittsburgh, and Oakland, California. The sampling frame differed somewhat across SWAN sites using random sampling from current census lists, commercial electric utility household lists, Kaiser Permanente membership lists, or random digit dialing. Details of the study methodology have been published previously.7 In brief, a two-stage recruitment process was used. First, in 1995 to 1997, a cross-sectional survey was conducted to assess eligibility for enrollment into a cohort study. In the second stage, eligible women were recruited from the cross-sectional sample for the longitudinal cohort. Eligibility criteria for participation in the SWAN cohort included: age 42–52 years, intact uterus and at least one ovary, pre- or early perimenopausal, not currently using exogenous hormone preparations affecting ovarian function, self-identification with one of each site’s designated race/ethnic groups, use of English or one of the other selected languages (Spanish, Japanese, Cantonese), and ability to give verbal consent to participate. For each of the seven sites, the recruitment goal for the longitudinal study was to obtain community-based samples of approximately 450 women composed of non-Hispanic white women and one designated minority group (black, Chinese, Hispanic, or Japanese) specific to each site. A total of 3302 women were enrolled in the longitudinal cohort and completed baseline data.

Common assessment protocols, approved by respective institutional review boards, were used across the seven study sites. At the baseline enrollment visit, after giving informed consent, women were asked to answer interview questions and a self-completed questionnaire. Their height and weight were measured. A blood sample to determine glucose level was taken following an 8-hour fast during days 2–7 of the follicular phase of the menstrual cycle. Blood was maintained at 40C (for up to 1 hour) until it was centrifuged. Serum was frozen at -80C until it was sent on dry ice to the Medical Research Laboratories. Throughout the study, the laboratories participated in, and remained certified by, the National Heart, Lung, and Blood Institute, Centers for Disease Control Part III program. Glucose was measured using a hexokinase-coupled reaction (Boehringer Mannheim Diagnostics, Indianapolis, IN).

Age, menopausal status, and ethnicity were self-reported. Menopausal status was classified as: early perimenopausal, indicating at least one menses had occurred in the past 3 months but had become less predictable; and premenopausal, indicating menses had occurred in the past 3 months with no change in predictability. Primary race/ethnicity was self-defined as black, non-Hispanic white, Chinese or Chinese American, Japanese or Japanese American, or Hispanic (Central American, Cuban or Cuban American, Dominican, Mexican or Mexican American, Puerto Rican, South American, Spanish or other Hispanic). Respondents could also specify "other," "mixed," or no primary ethnic affiliation; these latter women were not recruited into the longitudinal cohort.

Information on experience of urinary incontinence was obtained on the self-administered questionnaire. Participants were asked, "In the past year, have you ever leaked even a very small amount of urine involuntarily?" (yes/no). Those women who indicated incontinence were asked two questions related to the leakage. To assess frequency of incontinence, participants answered the question, "In the last month, on about how many days have you lost urine, even a small amount beyond your control?" (never/less than one day per week/several days per week/almost daily or daily), with responses scored from 1 to 4. Volume of leakage was estimated by the question, "How much urine do you leak?" A response of "A drop or two" was scored as 1, whereas other responses such as "Enough to change undergarments or to wear liner or pad" were scored as 2.

Severity of incontinence was derived from these two variables by multiplying the frequency score by the volume score. Slight incontinence was defined as a score of 1 or 2, moderate incontinence as a score of 3 or 4, and severe incontinence as a score greater than 4. Thus, we were able to calculate severity in a manner consistent with the scale developed and validated by Sandvik et al.6 Information about duration of urinary incontinence was obtained by the question, "How long ago did you notice leakage of urine?" (within the past year/1–2 years ago/3–4 years ago/5–9 years ago/10 or more years ago).

Women were asked to check off whether or not they had used specific measures to control or remedy the leakage. Participants who stated that they discussed leakage with a doctor, nurse, or other health care provider, had surgery, or were taking prescribed medications were categorized as having discussed incontinence with a health care professional. Participants were also asked to estimate the level of bother associated with leakage of urine on a scale from 0 to 10, where 0 = "Not bothered at all," 5 = "Somewhat bothered," and 10 = "Extremely bothered." For the purpose of the analysis, extent of bother was dichotomized at the median value, using a cutoff point of less than 5 or greater than or equal to 5, with the latter category including all women who indicated that they were somewhat to extremely bothered by the leakage. Nighttime voiding was assessed by the question, "How often do you usually get up from bed at night to urinate?," and the responses were classified as less than once per week or once per week or more.

Covariates included education (below college level/college or above), self-reported health status (excellent/very good/good/fair/poor), and parity (yes/no). Level of financial strain was assessed by the question, "How hard is it for you to pay for the very basics like food, housing, and medical care?" (very hard/somewhat hard/not hard at all). Smoking status was defined by two variables as currently smoke cigarettes (yes/no) and ever smoked cigarettes (yes/no). Women were categorized as diabetic if they reported that a health care provider had ever told them that they had diabetes or if their serum glucose level was greater than 125 mg/dL. Women were categorized as having leiomyomata if they reported that a health care provider had ever told them that they had the condition. Access to health care was evaluated using reported time since last visit to a health care provider (year or less/1–2 years or less/3–5 years/5 years or more/never). Body mass index was calculated as weight in kilograms divided by height in meters squared.

The analysis addressed three questions. We assessed the prevalence of urinary incontinence and risk factors associated with having any incontinence. Among women who reported any incontinence, we evaluated risk factors associated with having moderate/severe incontinence. Finally, we assessed the impact of incontinence on women’s daily lives using likelihood of discussing leakage with a health care provider, the level of bother associated with incontinence, and the likelihood of nighttime voiding as indicators of daily life impact. Of the 3302 women who were enrolled in the longitudinal cohort, 44 (1.3%) were missing information on presence of urinary incontinence; thus, 3258 women were eligible for this analysis. Information on severity of incontinence, discussing leakage with a health care provider, level of bother, and nighttime voiding was missing for an additional 23 (0.7%), 16 (0.5%), 11 (0.3%), and seven (0.2%) women, respectively. All analyses used SAS for Windows 6.12 (SAS Institute Inc., Cary, NC).

For each incontinence outcome, we first calculated frequency distributions for relevant covariates and then evaluated the association between the outcome variable and each independent variable using {chi}2 tests, analysis of variance, and Kruskal-Wallis tests as appropriate. Crude odds ratios and their corresponding 95% confidence intervals (CI) were calculated.

To evaluate risk factors associated with having any incontinence and with having moderate/severe incontinence, multiple logistic regression models were constructed for each race/ethnic group and for the total population of women. A three-stage approach was used to build the regression models. In the first stage, menopausal (perimenopausal versus premenopausal) status, age, and ethnicity were included. In the second stage, we individually added parity, BMI, diabetes, smoking, and leiomyomata. For continuous variables, age and BMI, we first examined the assumption of linearity. Age did not satisfy the assumption of linearity and was categorized as 47 or fewer years and more than 47 years. In the third stage, we included only those variables that were significantly associated with the outcome (P = .05) in the second stage. According to SWAN guidelines, site and ethnicity were retained in all models. To evaluate possible interactions with ethnicity, we examined whether the magnitude of the association differed by ethnicity in the ethnic-specific models. Possible interactions were then evaluated in the total population model. Log-likelihood ratio tests were conducted to examine the difference between models, and goodness-of-fit of the final model was assessed using Hosmer-Lemeshow {chi}2 statistics, based on differences between observed and predicted values. We also compared risk factors in women with no incontinence with those in women with moderate/severe incontinence. The results of this analysis are not shown because they were consistent with results from the analyses of mild-to-moderate/severe urinary incontinence.

Next, we considered daily impact on life by estimating the effect of severity of incontinence on likelihood of women reporting they had discussed the problem with a health care provider (yes/no), on self-reported level of bother (somewhat/very bothered), and on the likelihood of nighttime voiding (less than once per week/once per week or more). Multiple logistic regression was used to adjust for potential confounders including age, duration of incontinence, access to health care, and sleeping difficulties as appropriate.


    RESULTS
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
More than half of the 3258 women in this study reported experiencing urinary incontinence in the past year with almost 15% reporting moderate and 10% reporting severe incontinence (Table 1Go). Any incontinence was reported most frequently by white women and least frequently by Hispanic women. Consistent with the eligibility criteria, women ranged in age from 42 to 52 years with a mean age of 46.4 (±2.7) years. Table 2Go presents further information on the demographic and health characteristics of the study population.


View this table:
[in this window]
[in a new window]
 
Table 1. Prevalence of Any, Mild, Moderate, and Severe Urinary Incontinence in SWAN Population Overall and by Ethnic Group
 

View this table:
[in this window]
[in a new window]
 
Table 2. Demographic and Health Characteristics
 
Table 3Go presents the final adjusted model of risk factors for self-report of any urinary incontinence in the past year. Older age, perimenopausal status, and parity independently increased the odds of urinary leakage. Each unit increase in BMI was associated with a 5% increase in the odds of having leakage. Thus, an increase in BMI per standard deviation (7.13 units) was associated with a 43% increase of urinary incontinence.


View this table:
[in this window]
[in a new window]
 
Table 3. Adjusted Odds Ratios for Having Any Urinary Incontinence
 
Ethnic differences in the odds of reporting urinary leakage were present, but the association between ethnicity and incontinence is complex. In general nonwhite women were significantly less likely to report any incontinence. Among women without a history of leiomyomata, black women remained less likely than white women to report any incontinence; however, black women with a history of leiomyomata had a 1.8-fold increase in the odds (95% CI 1.22, 2.71) of having leakage as compared with white women with leiomyomata. This condition was not associated with incontinence in any other ethnic group.

Among women who reported having any urinary incontinence, biologic factors including perimenopausal status, BMI, diabetes, and current smoking were important risk factors for severity (Table 4Go). Consistent with SWAN guidelines, ethnicity was retained in the analysis, but neither age, ethnicity, nor education was associated with moderate or severe urinary incontinence.


View this table:
[in this window]
[in a new window]
 
Table 4. Adjusted Odds Ratios for Moderate/Severe Urinary Incontinence Among Women Reporting Incontinence
 
Table 5Go presents prevalence of discussing leakage with a health care provider, the level of bother women associate with their incontinence, and nighttime voiding, variables that we used as indicators of impact on daily life. Twelve percent of women had discussed the problem with a provider, with variation by ethnicity. Overall, 50% of women were somewhat to extremely bothered by the condition, with Hispanic women most likely and Chinese women least likely to report a high level of bother. Almost 60% of women reported having some nighttime voiding.


View this table:
[in this window]
[in a new window]
 
Table 5. Prevalence of Discussing Incontinence With Health Care Provider, Level of Bother, and Nighttime Voiding by Ethnicity
 
Severity of incontinence was very strongly associated with the likelihood that women had discussed their problem with a health care provider, but no differences were observed by ethnicity (Table 6Go). Severity was strongly associated with level of bother. Moreover, Hispanic women and women reporting financial strain had increased odds of reporting a high level of bother. Severity also was associated with nighttime voiding.


View this table:
[in this window]
[in a new window]
 
Table 6. Likelihood of Discussing Incontinence With Health Care Provider, Level of Bother, and Nighttime Voiding
 

    DISCUSSION
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The 57% prevalence of urinary incontinence that we report is higher than the 30% to 41% reported by some2,8 and less than the 69% reported by others1 who surveyed comparable age groups using symptom recall in the past year as the measure. One explanation for the higher prevalence in the study reported here is that in the past few years advertising in the United States for incontinence medications and products has increased tremendously, perhaps increasing women’s willingness to disclose the condition. Our finding of severity level distributions of slight (32%), moderate (15%), and severe (10%) is somewhat higher than, but very similar to, the pattern described by Sandvik et al in 1993 of respectively 31%, 14%, and 7% for women aged 40–60 years,6 but much higher than the most recent report of the Norwegian Epidemiology of Incontinence in the County of Nord-Trøndelag study of 13%, 8%, and 5%.9

The few studies that have compared incontinence in white and black women have reported inconsistent findings. Using prevalence in white women as the reference, other ethnicities in our sample were approximately two to three times less likely to report any incontinence. This finding converges with those of others10,11 with respect to decreased risk in black women and is consistent with higher levels of pelvic floor strength reported in this ethnic group.12 With respect to prediction of severity, the effect of ethnicity was not significant. A partial explanation for this may be the relatively low numbers of Chinese, Japanese, and Hispanic women in our sample. However, our black representation is robust and the lack of a race/ethnicity effect when severity is taken into account is convergent with the findings of Fultz et al10 that race was not related to severity of urine loss (as measured by frequency). It is noteworthy that in the study presented here, significant effects for ethnicity disappeared when BMI was entered into the model for prediction of severity (Table 4Go). Study of ethnicity as a risk factor has not consistently taken BMI into account. Our findings suggest that BMI may subsume the effects of ethnicity on severity.

There are widely disparate levels of agreement in the literature for the contribution of various other factors to incontinence risk. Consideration of severity level enabled us to disentangle some of this confusion. Current evidence supports the association of age, parity, and BMI with incontinence: prevalence is greater among older as compared with younger women,13,14 in those with a history of vaginal birth as compared with their nulliparous counterparts,15,16 and in more obese as compared with thinner women.17,18 The published evidence is less convincing for the contribution of menopausal status, cigarette smoking, and diabetes mellitus. Our data suggest that menopausal status (perimenopause versus premenopause), BMI, and diabetes are significant predictors of any incontinence as well as of severity. BMI has long been recognized as a risk factor for the development of incontinence3; our analysis further demonstrates the contribution of BMI to increased severity. There have been conflicting reports about the role of menopause, with some investigators finding prevalence equal between pre- and postmenopausal women, but severity greater in postmenopause.8 Others have reported lower levels of incontinence after menopause.19 We focus on the perimenopause, and our data suggest that perimenopause as compared with premenopause is a risk factor for both the presence of any incontinence and increasing severity. Moreover, perimenopausal status was a stronger and more consistent predictor than was age. Our sample was restricted to 42–52 years of age, resulting in a relatively homogeneous age span that could contribute to the decreased effect of age. However, our results are consistent with those reported by others who found incontinence more prevalent in perimenopausal than premenopausal women.20 The neurologic pathology of diabetes mellitus would be expected to increase the risk of incontinence, but the demonstration of such a relationship has been inconsistent.21,22 We show diabetes to increase by more than 50% the risk of any incontinence and of increased severity.

In comparison with their white counterparts, it is noteworthy that black women without a history of leiomyomata had 1/3 the risk of incontinence, whereas those with such history had an increased risk of greater than 80%. We speculate that the propensity of black women to develop larger leiomyomata likely increases the prevalence of stress urinary incontinence, but without the ability to categorize type of incontinence in this data set, we were unable to test that hypothesis. Designation as a current smoker was associated with increased risk of moderate/severe incontinence levels. Earlier studies reported current smoking to be a contributing factor, but did not consider severity.23,24 This association of current versus previous history of cigarette smoking may be due to the greater likelihood of a smoker’s cough, which would yield increased intra-abdominal pressure as a factor in the significant association with severity.

Although women of greater parity were more likely to report any incontinence, variation in parity level was not associated with severity. Cumulative effects of parity have been observed in other studies,25 but in the study reported here, severe urinary incontinence was as common in primiparas as in multiparas, and higher parity did not necessarily add to symptom severity. This finding should be viewed with caution, given the inclusion of cesarean within the parity designation. Reported history of diabetes was considered sufficient basis for categorization as diabetic, regardless of current fasting glucose levels. Thus, a woman who might have experienced gestational diabetes could be classified as diabetic. This convention increases the potential association of diabetes with incontinence through parity; however, the association of diabetes persisted even when controlling for parity, reflecting the robustness of diabetes as a predictor.

More than 8% (95% CI 6.7, 9.2) of our respondents had not visited a health care provider in the previous year. This proportion is slightly more than the 6.7% (95% CI 6.4%, 7.1%) reported for the year 2001 in the National Health Interview surveys for older women.26 The higher proportion in our sample likely reflects greater numbers of ethnically diverse, lower-income cases. We expected to find a relationship between severity level and likelihood of discussing incontinence with a health care provider as has been shown in other studies.27,28 Even when controlling for ethnicity, site, duration, and access to health care, this relationship was significant (Table 5Go). These findings underline the substantial impact on women’s daily lives that moderate and severe urinary incontinence impose.

Impact on daily life is further demonstrated in the significant and progressive level of bother reported by women as the level of severity increases from mild to moderate to severe (Table 6Go). This finding is consistent with those of others,6,9 but we further show ethnic differences in the bothersomeness of this condition. Hispanic and black women experienced greater levels of bother with increasing severity than did their white counterparts. This suggests that all women should be carefully screened for urinary incontinence, despite decreased risk in nonwhite ethnic groups.

Historically, nighttime voiding has been an accepted aspect of aging, and various medical textbooks present it as a normal circumstance after the age of 50.29–31 In fact, 34% of our sample reported voiding "once a night every night or more often." A recent survey of communitydwelling women showed only 37% of those 40–60 years never experienced nighttime voiding, but no assessment of a relationship with incontinence was reported.1 Further analysis of our data was consistent showing only 40% never or rarely experiencing nighttime voiding. However, as presented in Table 6Go, increasing severity of urinary incontinence was significantly associated with nighttime voiding. In other studies, greater levels of nighttime voiding correlated positively with increased frequency of incontinence, but volume was not considered as an aspect of severity.2,8 We found incontinence severity to be an independent predictor of nighttime voiding. That is, women with no or mild incontinence were significantly less likely to experience frequent nighttime voiding than women with moderate or severe levels. Thus, the question emerges, might nighttime voiding decrease with effective treatment of incontinence? Prospective evidence of a beneficial effect of improved continence was demonstrated recently when nighttime voiding diminished significantly as incontinence episodes diminished.32

Taken together, it is clear that large numbers of women are affected by urinary incontinence. The proportion in the moderate and severe categories underlines the threat to women’s physical and emotional well-being. It is noteworthy that 25% of our sample experienced at least enough leakage to warrant wearing protection or changing undergarments on several days per week. More consistent screening without regard to ethnicity and more effective patient education about mutable risk factors such as BMI and current smoking are warranted.


    Footnotes
 
The Study of Women’s Health Across the Nation was funded by the National Institute on Aging, the National Institute of Nursing Research, and the Office of Research on Women’s Health of the National Institutes of Health. Supplemental funding from the National Institute of Mental Health, the National Institute on Child Health and Human Development, the National Center on Complementary and Alternative Medicine, the Office of Minority Health, and the Office of AIDS Research is also gratefully acknowledged. Clinical Centers: University of Michigan, Ann Arbor, MI (U01 NR04061, MaryFran Sowers, PI); Massachusetts General Hospital, Boston, MA (U01 AG12531, Joel Finkelstein, PI); Rush University, Rush-Presbyterian-St. Luke’s Medical Center, Chicago, IL (U01 AG12505, Lynda Powell, PI); University of California, Davis/Kaiser (U01 AG12554, Ellen Gold, PI); University of California, Los Angeles, CA (U01 A12539, Gail Greendale, PI); University of Medicine and Dentistry of New Jersey-New Jersey Medical School, Newark, NJ (U01 AG12535, Gerson Weiss, PI); and the University of Pittsburgh, Pittsburgh, PA (U01 AG12546, Karen Matthews, PI). Central Laboratory: University of Michigan, Ann Arbor, MI (U01 AG12495, Central Ligand Assay Satellite Services, Dan McConnell, PI). Coordinating Center: New England Research Institutes, Watertown, MA (U01AG12553, Sonja McKinlay, PI). Project Officers: Carol Hudgings, Sheryl Sherman. Steering Committee Chair: Jennifer L. Kelsey.

The manuscript was reviewed by the Publications and Presentations Committee of the Study of Women’s Health Across the Nation and has its endorsement.

The authors thank the study staff at each site and all of the women who participated in the Study of Women’s Health Across the Nation.

PII S0029-7844(02)02241-X

Received December 28, 2001. Received in revised form May 9, 2002. Accepted May 30, 2002.


    REFERENCES
 TOP
 ABSTRACT
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
1. Swithinban L, Abrams P. Lower urinary tract symptoms in community-dwelling women: Defining diurnal and nocturnal frequency and ‘the incontinence case’. BJU Int 2000;88:18–22.

2. Samulsson E, Victor A, Tibblin G. A population study of urinary incontinence and nocturia among women ages 20–59 years. Prevalence, well-being and wish for treatment. Acta Obstet Gynecol Scand 1997;76:74–80.[Medline]

3. Hunskaar S, Arnold EP, Burgio K, Diokno AC, Herzog AR, Mallett VT. Epidemiology and natural history of urinary incontinence. Int Urogynecol J 2000;11:301–19.

4. Nygaard IE, Lemke JH. Urinary incontinence in rural older women: Prevalence, incidence and remission. J Am Geriatr Soc 1996;44:1049–54.[Medline]

5. Samuelsson EC, Victor FT, Arne MD, Svardsudd KF. Five-year incidence and remission rates of female urinary incontinence in a Swedish population less than 65 years old. Am J Obstet Gynecol 2000;183:568–74.[Medline]

6. Sandvik H, Hunskaar S, Seim A, Hermstad R, Vanvik A, Bratt H. Validation of a severity index in female urinary incontinence and its implementation in an epidemiological survey. J Epidemiol Comm Heal 1993;47:497–9.[Abstract]

7. Sowers MF, Crawford S, Sternfeld B, Morgenstein D, Gold E, Greendale G, et al. Design, survey sampling and recruitment methods of SWAN: A multi-center, multiethnic, community-based cohort study of women and the menopausal transition. In: Wren J, Lobo RA, Kelsey J, Marcus R, eds. Menopause: Biology and pathobiology. San Diego: Academic Press, 2000:175–88.

8. Rekers H, Drogendijk AC, Valkenburg HA, Riphagen F. The menopause, urinary incontinence and other symptoms of the genitourinary tract. Maturitas 1992;15: 101–11.[Medline]

9. Hannestad YS, Rortveit G, Sandvik H, Hunskaar S. A community-based epidemiological survey of female urinary incontinence: The Norwegian EPINCONT study. J Clin Epidemiol 2000;53:1150–7.[Medline]

10. Fultz NH, Herzog AR, Raghunathan TE, Wallace RB, Diokno AC. Prevalence and severity of urinary incontinence in older African American and Caucasian women. J Gerontol 1999;54A:M299–M303.

11. Bump RC. Racial comparisons and contrasts in urinary incontinence and pelvic organ prolapse. Obstet Gynecol 1993;81:421–5.[Abstract]

12. Howard D, DeLancey JOL, Tunn R, Ashton-Miller JA. Racial differences in the structure and function of the stress urinary continence mechanism. Obstet Gynecol 2000;95: 713–7.[Abstract/Free Full Text]

13. Burgio KL, Matthews KA, Engel BT. Prevalence, incidence and correlates of urinary incontinence in healthy, middle-aged women. J Urol 1991;146:1255–9.[Medline]

14. Lam GW, Foldspang A, Elving LB, Mommsen S. Urinary incontinence in women ages 30–59 years. An epidemiologic study. Ugeskr Laeger 1990;152:3244–6.[Medline]

15. Milsom I, Ekelund P, Molander U, Arvidsson L, Areskoug B. The influence of age, parity, oral contraception, hysterectomy and menopause on the prevalence of urinary incontinence in women. J Urol 1993;149:1459–62.[Medline]

16. Harrison GL, Memel DS. Urinary incontinence in women: Its prevalence and its management in a health promotion clinic. Br J Gen Pract 1994;44:149–52.[Medline]

17. Thom DH, Van Den Eeden SK, Brown JS. Evaluation of parturition and other reproductive variables as risk factors for urinary incontinence in later life. Obstet Gynecol 1997; 90:983–9.[Abstract]

18. Mommsen S, Foldspang A. Body mass index and adult female urinary incontinence. World J Urol 1994;12: 319–22.[Medline]

19. Brown JS, Seeley DG, Fong J, Black DM, Ensrud KE, Grady D. Urinary incontinence in older women: Who is at risk? Obstet Gynecol 1996;87:715–21.[Abstract]

20. Sherburn M, Guthrie JR, Dudley EC, O’Connell HE, Dennerstein L. Is continence associated with menopause? Obstet Gynecol 2001;98:628–33.[Abstract/Free Full Text]

21. Kaplan SA, Te AE, Blaivas JG. Urodynamic findings in patients with diabetic cystopathy. J Urol 1995;153:342–4.[Medline]

22. Diokno AC, Brock BM, Herzog AR, Bromberg J. Medical correlates of urinary incontinence in the elderly. Urology 1990;36:129–38.[Medline]

23. Bump RC, McClish DK. Cigarette smoking and urinary incontinence in women. Am J Obstet Gynecol 1992;167: 1213–8.[Medline]

24. Tampakoudis P, Tantanassis T, Grimbizis G, Papaletsos M, Mantalenakis S. Cigarette smoking and urinary incontinence in women: A new calculative method of estimating the exposure to smoke. Eur J Obstet Gynecol Reprod Biol 1995;63:27–30.[Medline]

25. Sommer P, Bauer T, Nielsen KK, Kristensen ES, Hermann GG, Steven K, et al. Voiding patterns and prevalence of incontinence in women. A questionnaire survey.Br J Urol 1990;66:12–5.[Medline]

26. [Family core component of the 1997–2001 National Health Interview Surveys]. Hyattsville, Maryland: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics, Division of Data Services. Available at: http://www.cdc.gov/nchs/data/nhis/measure03.pdf. Accessed 2002 Oct 18.

27. Burgio KL, Ives DG, Locher JL, Arena VC, Kuller LH. Treatment seeking for urinary incontinence in older adults. J Am Geriatr Soc 1994;42:208–12.[Medline]

28. Herzog AR, Fultz NH, Normolle DP, Brock BM, Diokno AC. Methods used to manage urinary incontinence by older adults in the community. J Am Geriatr Soc 1989;37: 339–47.[Medline]

29. Engelberg SJH, McDowell BJ, Lovell A. Urinary function. In: Lueckenotte AG, ed. Gerontologic nursing. St. Louis: Mosby, 2000:586.

30. Evans JG, Williams TF, Beattie BL, Michel JP, Wilcock GK. Oxford textbook of geriatric medicine. New York: Oxford University Press, 2000.

31. Robertson JR, Hebert DB. Gynecologic urology. In: DeCherney AH, Pernoll MR, eds. Current obstetric & gynecologic diagnosis & treatment. Norwalk, Connecticut: Appleton & Lange, 1994:831–45.

32. Sampselle CM, Wyman JF, Thomas KK, Newman DK, Gray M, Dougherty M, et al. Continence for women: A test of AWHONN’s evidence-based protocol in clinical practice. JOGNN 2000;29:18–26.[Medline]




This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
T. A. Shamliyan, R. L. Kane, J. Wyman, and T. J. Wilt
Systematic Review: Randomized, Controlled Trials of Nonsurgical Treatments for Urinary Incontinence in Women
Ann Intern Med, March 18, 2008; 148(6): 459 - 473.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
Yan Wen, Y.-Y. Zhao, M. L. Polan, and B. Chen
Effect of Relaxin on TGF-{beta}1 Expression in Cultured Vaginal Fibroblasts From Women With Stress Urinary Incontinence
Reproductive Sciences, March 1, 2008; 15(3): 312 - 320.
[Abstract] [PDF]


Home page
Am J EpidemiolHome page
D. H. Thom
Invited Commentary: The Contribution of the BACH Survey to the Epidemiology of Urinary Incontinence
Am. J. Epidemiol., February 15, 2008; 167(4): 400 - 403.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
S. L. Tennstedt, C. L. Link, W. D. Steers, and J. B. McKinlay
Prevalence of and Risk Factors for Urine Leakage in a Racially and Ethnically Diverse Population of Adults: The Boston Area Community Health (BACH) Survey
Am. J. Epidemiol., February 15, 2008; 167(4): 390 - 399.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
J. M. Lawrence, E. S. Lukacz, I.-L. A. Liu, C. W. Nager, and K. M. Luber
Pelvic Floor Disorders, Diabetes, and Obesity in Women: Findings from the Kaiser Permanente Continence Associated Risk Epidemiology Study
Diabetes Care, October 1, 2007; 30(10): 2536 - 3541.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
L. E. Waetjen, S. Liao, W. O. Johnson, C. M. Sampselle, B. Sternfield, S. D. Harlow, E. B. Gold, and for the Study of Women's Health Across the Nation
Factors Associated with Prevalent and Incident Urinary Incontinence in a Cohort of Midlife Women: A Longitudinal Analysis of Data: Study of Women's Health Across the Nation
Am. J. Epidemiol., February 1, 2007; 165(3): 309 - 318.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
A. J. Huang, J. S. Brown, A. M. Kanaya, J. M. Creasman, A. I. Ragins, S. K. Van Den Eeden, and D. H. Thom
Quality-of-Life Impact and Treatment of Urinary Incontinence in Ethnically Diverse Older Women.
Arch Intern Med, October 9, 2006; 166(18): 2000 - 2006.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
S. L. Jackson, D. Scholes, E. J. Boyko, L. Abraham, and S. D. Fihn
Predictors of Urinary Incontinence in a Prospective Cohort of Postmenopausal Women.
Obstet. Gynecol., October 1, 2006; 108(4): 855 - 862.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
J. S. Brown, E. Vittinghoff, F. Lin, L. M. Nyberg, J. W. Kusek, and A. M. Kanaya
Prevalence and Risk Factors for Urinary Incontinence in Women With Type 2 Diabetes and Impaired Fasting Glucose: Findings from the National Health and Nutrition Examination Survey (NHANES) 2001-2002.
Diabetes Care, June 1, 2006; 29(6): 1307 - 1312.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
J. S. Brown, R. Wing, E. Barrett-Connor, L. M. Nyberg, J. W. Kusek, T. J. Orchard, Y. Ma, E. Vittinghoff, A. M. Kanaya, and for the Diabetes Prevention Program Research Group
Lifestyle Intervention Is Associated With Lower Prevalence of Urinary Incontinence: The Diabetes Prevention Program
Diabetes Care, February 1, 2006; 29(2): 385 - 390.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
S. L. Jackson, D. Scholes, E. J. Boyko, L. Abraham, and S. D. Fihn
Urinary Incontinence and Diabetes in Postmenopausal Women
Diabetes Care, July 1, 2005; 28(7): 1730 - 1738.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
J. L. Melville, W. Katon, K. Delaney, and K. Newton
Urinary Incontinence in US Women: A Population-Based Study
Arch Intern Med, March 14, 2005; 165(5): 537 - 542.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
S. L. Hendrix, B. B. Cochrane, I. E. Nygaard, V. L. Handa, V. M. Barnabei, C. Iglesia, A. Aragaki, M. J. Naughton, R. B. Wallace, and S. G. McNeeley
Effects of Estrogen With and Without Progestin on Urinary Incontinence
JAMA, February 23, 2005; 293(8): 935 - 948.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
J. S. Brown, H. Wessells, M. B. Chancellor, S. S. Howards, W. E. Stamm, A. E. Stapleton, W. D. Steers, S. K. Van Den Eeden, and K. T. McVary
Urologic Complications of Diabetes
Diabetes Care, January 1, 2005; 28(1): 177 - 185.
[Full Text] [PDF]


Home page
Obstet GynecolHome page
I. E. Nygaard and M. Heit
Stress Urinary Incontinence
Obstet. Gynecol., September 1, 2004; 104(3): 607 - 620.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
R A. Jackson, E Vittinghoff, A M. Kanaya, T P. Miles, H E. Resnick, S B. Kritchevsky, E M. Simonsick, and J S. Brown
Urinary Incontinence in Elderly Women: Findings From the Health, Aging, and Body Composition Study
Obstet. Gynecol., August 1, 2004; 104(2): 301 - 307.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
L. R. Berkowitz
Case 20-2004 - A 46-Year-Old Woman with Pelvic-Floor Relaxation after a Second Vaginal Delivery
N. Engl. J. Med., June 24, 2004; 350(26): 2699 - 2706.
[Full Text] [PDF]


Home page
JAMAHome page
J. M. Holroyd-Leduc and S. E. Straus
Management of Urinary Incontinence in Women: Scientific Review
JAMA, February 25, 2004; 291(8): 986 - 995.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sampselle, C. M.
Right arrow Articles by Bondarenko, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sampselle, C. M.
Right arrow Articles by Bondarenko, I.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS